Table of contents
Volume 98, Issue 11
Published online 27 May 2008 (1729-1880)
Minireviews |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letter to the Editor |
Corrigendum
Editorial
The screening mammography paradox: better when found, perhaps better not to find
D A Berry
Br J Cancer 98: 1729-1730; doi:10.1038/sj.bjc.6604349
Minireviews
Circulating endothelial cells in oncology: pitfalls and promises
M H Strijbos, J W Gratama, J Kraan, C H Lamers, MA den Bakker and S Sleijfer
Br J Cancer 98: 1731-1735; doi:10.1038/sj.bjc.6604383
Risks and benefits of bisphosphonates
R E Coleman
Br J Cancer 98: 1736-1740; doi:10.1038/sj.bjc.6604382
Clinical Studies
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
G C Wishart, D C Greenberg, P D Britton, P Chou, C H Brown, A D Purushotham and S W Duffy
Br J Cancer 98: 1741-1744; doi:10.1038/sj.bjc.6604368
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer
E Montagna, V Bagnardi, N Rotmensz, J Rodriguez, P Veronesi, A Luini, M Intra, E Scarano, A Cardillo, R Torrisi, G Viale, A Goldhirsch and M Colleoni
Br J Cancer 98: 1745-1752; doi:10.1038/sj.bjc.6604384
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases
D Generali, A Dovio, M Tampellini, M Tucci, S Tedoldi, M Torta, S Bonardi, G Allevi, S Aguggini, M Milani, A L Harris, A Bottini, L Dogliotti, A Angeli and A Berruti
Br J Cancer 98: 1753-1758; doi:10.1038/sj.bjc.6604390
Radiographer gender and breast-screening uptake
P Fitzpatrick, A Winston and T Mooney
Br J Cancer 98: 1759-1761; doi:10.1038/sj.bjc.6604385
A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours
I Contreras-Hernández, J F Mould-Quevedo, A Silva, G Salinas-Escudero, M A Villasís-Keever, V Granados-García, G Dávila-Loaiza, J A Petersen and J Garduño-Espinosa
Br J Cancer 98: 1762-1768; doi:10.1038/sj.bjc.6604367
Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer
N B Leighl, F A Shepherd, D Zawisza, R L Burkes, R Feld, J Waldron, A Sun, D Payne, A Bezjak and M H N Tattersall
Br J Cancer 98: 1769-1773; doi:10.1038/sj.bjc.6604395
A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers
P A Vasey, M Gore, R Wilson, G Rustin, H Gabra, J-P Guastalla, E P Lauraine, J Paul, K Carty and S Kaye on behalf of the Scottish Gynaecological Cancer Trials Group
Br J Cancer 98: 1774-1780; doi:10.1038/sj.bjc.6604371
Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity
K J Wernli, P A Newcomb, J M Hampton, A Trentham-Dietz and K M Egan
Br J Cancer 98: 1781-1783; doi:10.1038/sj.bjc.6604392
Translational Therapeutics
Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI
G Gambarota, W Leenders, C Maass, P Wesseling, B van der Kogel, O van Tellingen and A Heerschap
Br J Cancer 98: 1784-1789; doi:10.1038/sj.bjc.6604389
Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines
N Barabutis and A V Schally
Br J Cancer 98: 1790-1796; doi:10.1038/sj.bjc.6604386
Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus
J P Boni, C Leister, J Burns and B Hug
Br J Cancer 98: 1797-1802; advance online publication, May 6, 2008; doi:10.1038/sj.bjc.6604376
Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance
E L Leung, M Fraser, R R Fiscus and B K Tsang
Br J Cancer 98: 1803-1809; doi:10.1038/sj.bjc.6604375
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response
S Cheetham, M J Tang, F Mesak, H Kennecke, D Owen and I T Tai
Br J Cancer 98: 1810-1819; advance online publication, May 6, 2008; doi:10.1038/sj.bjc.6604377
Molecular Diagnostics
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
A M J Langers, C F M Sier, L J A C Hawinkels, F J G M Kubben, W van Duijn, J J van der Reijden, C B H W Lamers, D W Hommes and H W Verspaget
Br J Cancer 98: 1820-1823; doi:10.1038/sj.bjc.6604380
Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer
K Ishikawa, Y Kamohara, F Tanaka, N Haraguchi, K Mimori, H Inoue and M Mori
Br J Cancer 98: 1824-1829; doi:10.1038/sj.bjc.6604379
Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study
M Wager, P Menei, J Guilhot, P Levillain, S Michalak, B Bataille, J-L Blanc, F Lapierre, P Rigoard, S Milin, F Duthe, D Bonneau, C-J Larsen and L Karayan-Tapon
Br J Cancer 98: 1830-1838; doi:10.1038/sj.bjc.6604378
Mitochondria-dependent signalling pathway are involved in the early process of radiation-induced bystander effects
S Chen, Y Zhao, W Han, G Zhao, L Zhu, J Wang, L Bao, E Jiang, A Xu, T K Hei, Z Yu and L Wu
Br J Cancer 98: 1839-1844; advance online publication, May 13, 2008; doi:10.1038/sj.bjc.6604358
Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment
C Badie, S Dziwura, C Raffy, T Tsigani, G Alsbeih, J Moody, P Finnon, E Levine, D Scott and S Bouffler
Br J Cancer 98: 1845-1851; advance online publication, May 20, 2008; doi:10.1038/sj.bjc.6604381
Epidemiology
Diagnostic radiation procedures and risk of prostate cancer
P Myles, S Evans, A Lophatananon, P Dimitropoulou, D Easton, T Key, R Pocock, D Dearnaley, M Guy, S Edwards, L O'Brien, B Gehr-Swain, A Hall, R Wilkinson, R Eeles and K Muir
Br J Cancer 98: 1852-1856; advance online publication, May 13, 2008; doi:10.1038/sj.bjc.6604370
Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran
D Nasrollahzadeh, F Kamangar, K Aghcheli, M Sotoudeh, F Islami, C C Abnet, R Shakeri, A Pourshams, H A Marjani, M Nouraie, M Khatibian, S Semnani, W Ye, P Boffetta, S M Dawsey and R Malekzadeh
Br J Cancer 98: 1857-1863; advance online publication, May 13, 2008; doi:10.1038/sj.bjc.6604369
Association of physical activity with cancer incidence, mortality, and survival: a population-based study of men
N Orsini, C S Mantzoros and A Wolk
Br J Cancer 98: 1864-1869; doi:10.1038/sj.bjc.6604354
Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study
S Christensen, L Pedersen, M Grijota, J B Kornum, A Beiderbeck and H T Sørensen
Br J Cancer 98: 1870-1875; doi:10.1038/sj.bjc.6604393
Lower breast cancer survival in mothers of children with a malignancy: a national study
H Olsson, S Magnusson and A Bladström
Br J Cancer 98: 1876-1878; advance online publication, May 6, 2008; doi:10.1038/sj.bjc.6604350
Letter to the Editor
Japanese mobile phone study
B Hocking
Br J Cancer 98: 1879; doi:10.1038/sj.bjc.6604397
Corrigendum
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro FREE
P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton, M J Henderson, D N Saunders, B S Gloss, K I Patterson, J L Clancy, V A Heinzelmann-Schwarz, R Murali, R A Scolyer, Y Zeng, E D Williams, L Scurr, A DeFazio, Di Quinn, C K W Watts, N F Hacker, S M Henshall and R L Sutherland
Br J Cancer 98: 1880; doi:10.1038/sj.bjc.6604419
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.